Alexion Pharma (ALXN) Gains Amid Conference Call
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Investment income: 1.87M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Investment income: 1.87M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) gained on statements made during its conference call.
It sees Q1 product revenue of $585-$590. 2015 tax rate is seen at 7%-9% vs 13%-15% prior. It expected US and EU decisions on Asfotase Alfa by mid-year, and Japan by the end of the year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Google Gemini now has over 1B monthly users - CEO
- Avalonbay Communities (AVB) dropped from S&P 500
- Reddit (RDDT) added to S&P 500
Create E-mail Alert Related Categories
Guidance, Management Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
